Advaxis, Inc. (NASDAQ: ADXS), a Princeton-based biotechnology company focused on the development of cancer immunotherapies, recently announced that it has entered into direct placement financing with healthcare specialist investors worth around $30 million. Advaxis will be selling 2.2 million shares of its common stock at $13.50 per share. Advaxis is offering these shares pursuant to a shelf registration statement on Form S-3 (File No. 333-203497) that, on April 27, 2015, the Securities and Exchange Commission (SEC) deemed effective. Jefferies LLC and Barclays Capital, Inc. are the companies acting as the lead intermediaries, with Cantor Fitzgerald & Co. and Guggenheim Securities, LLC assisting.
The offering will come with a prospectus that will be filed with the SEC. Once put together, the prospectus will be available from:
Jefferies LLC
520 Madison Avenue, 2nd Floor
New York, NY, 10022
Attention to Equity Syndicate Prospectus Department
877-547-6340
prospectus_department@jefferies.com
Barclays Capital Inc. c/o Broadridge Financial Solutions
1155 Long Island Avenue
Edgewood, New York 11717
(888) 603-5847
Barclaysprospectus@broadridge.com
You will also find a prospectus supplement and other supporting documents on the SEC website at www.sec.gov.
This release of this statement was not an offer by Advaxis to sell or to purchase. Also, none of the above will be sold in any state where the offer is in any way against the law before being registered or having qualified under the securities laws of said state or jurisdiction.
For more information, visit www.Advaxis.com
About NetworkNewsWire
NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing network of more than 5,000 key distribution outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge. For more information, visit www.networknewswire.com.
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
Editor@NetworkNewsWire.net
